Heron Therapeutics (STU:AXD2) Interest Expense : €0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Heron Therapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Heron Therapeutics's interest expense for the three months ended in Mar. 2024 was € 0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was €0.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Heron Therapeutics's Operating Income for the three months ended in Mar. 2024 was € -4.4 Mil. Heron Therapeutics's Interest Expense for the three months ended in Mar. 2024 was € 0.0 Mil. GuruFocus does not calculate Heron Therapeutics's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Heron Therapeutics Interest Expense Historical Data

The historical data trend for Heron Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heron Therapeutics Interest Expense Chart

Heron Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-1.33

-1.56

-2.13

-2.34

-3.55

Heron Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

Heron Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Heron Therapeutics (STU:AXD2) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Heron Therapeutics's Interest Expense for the three months ended in Mar. 2024 was €0.0 Mil. Its Operating Income for the three months ended in Mar. 2024 was €-4.4 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was €162.0 Mil.

Heron Therapeutics's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

GuruFocus does not calculate Heron Therapeutics's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Heron Therapeutics (STU:AXD2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heron Therapeutics Inc (STU:AXD2) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

HRTX:USA AXD2:Germany

Address

4242 Campus Point Court, Suite 200, San Diego, CA, USA, 92121

Website

https://www.herontx.com

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.

Heron Therapeutics (STU:AXD2) Headlines

No Headlines